Eurofins Scientific has acquired IDmyk, a leading laboratory specialized in the areas of detection, identification and molecular typing of microorganisms for the pharmaceutical industry. The acquisition reinforces Eurofins' pharmaceutical quality control offering, and complements its existing capabilities in microbiological analysis.

Since 2000, IDmyk has developed market-leading expertise in establishing the genetic identity of microorganisms to support product or process-related investigations. As such, IDmyk has the largest validated proprietary database for Good Manufacturing Practice (GMP) identification service in the industry. These, combined with Eurofins' existing identification capabilities, strengthen the Group's pharmaceutical QC service offering. Furthermore, rolling-out the methods to the relevant laboratories across the Group network will allow Eurofins to benefit from reduced costs given the use of proprietary reagents in the processes.